Together, these findings identify Cxcr6+ T cells as key mediators of immune-driven tubular cell death during maladaptive repair and suggest that targeting the CXCL16-CXCR6 axis may mitigate tubular injury and slow AKI-to-CKD progression. The gene discussed is CXCL16; the disease is chronic kidney disease.